Greenphire Launches GreenSpace App and Expands Global Payment Functionality

New digital experience and expanded global payment capabilities broaden trial access, promoting convenience, connectivity and regional preference for participants around the world

KING OF PRUSSIA, Pa., April 25, 2023 /PRNewswire/ -- Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, today announced the expansion of its trusted participant-centered offerings with a robust series of solution enhancements. To enable sponsors, CROs and sites to deliver a consistent experience for trial participants everywhere, the company has unveiled a new patient-facing digital platform, GreenSpace, coupled with increased international payment functionality and flexibility, dramatically improving access, engagement, and retention globally.

GreenSpace enhances the trial experience for participants around the world. Unlike other solutions available in the market today, GreenSpace offers a unified digital experience accessible via iOS and Android devices, or through an internet browser. The comprehensive platform provides easy access to trial-related information and activities such as financial views and account details, submission of receipts for reimbursement, visit and travel itinerary details, delivery of surveys and insights and more.

"Greenphire is dedicated to making the patient journey better in every way. With the launch of GreenSpace, we have taken a giant leap forward in achieving that goal by streamlining how patients interact with sites, track clinical trial activities, and get reimbursed. We are proud to be at the forefront of patient and site centric innovation, delivering a game-changing product that is transforming patient experiences around the world," said Kyle Cunningham, Chief Product Officer, Greenphire.

In addition to GreenSpace, Greenphire has also expanded its proven global payment offerings available through ClinCard, the industry's leading technology for international patient reimbursement automation. With the continued goal of supporting patients' requirements and preferences anywhere in the world, the solution will offer a comprehensive suite of payment modalities for both banked and unbanked study populations. This puts the power in patients' hands, providing them with the ability to choose from options that best align with their personal needs, including reloadable debit cards, virtual cards, digital wallets, email to money and bank transfers that are real-time, low cost to customers and zero fees for patients. With the goal of supporting patients anywhere in the world, Greenphire's enhancements will further enable regional preference, patient choice, and improved global access.

"Persistent financial and logistical burdens remain a key impediment to patient involvement in clinical trials," said Jim Murphy, CEO, Greenphire. "Our core objective at Greenphire is to break down those barriers – to understand the challenges faced by sponsors and CROs, sites and participants, and continuously deliver scalable technology solutions that broaden access, drive convenience, and introduce efficiency and transparency worldwide."

Additional features and functionalities will be deployed throughout the year. To learn more about GreenSpace and Greenphire's proven suite of technology solutions, please visit: Greenphire.com.

About Greenphire
Greenphire's suite of best-in-class technology solutions enables clients to prioritize the patient journey, so treatments and cures can be delivered to those who need them faster.

Committed to modernizing and integrating each step in the participant journey and the overall clinical trial lifecycle, Greenphire has established an unmatched suite of patient convenience solutions, including a mobile-enabled technology platform which offers a personalized and empowering end-to-end participant experience from trial identification (patient registry) through participation. ClinCard® and ConneX® remove financial and logistical barriers, simplifying the delivery of global patient convenience initiatives and improving recruitment and retention. Greenphire's EnvisiX™ and eClinicalGPS® transform the budgeting and site payment process, resulting in expedited study start up and improved site sustainability. Learn more at www.greenphire.com

Media Contact: 
Lindsay Hull, Zer0 to 5ive for Greenphire
[email protected]

SOURCE Greenphire